Myocarditis: What’s new for 2025

2 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
Guest: Leslie T. Cooper Jr., M.D.
Host: Kyle W. Klarich, M.D.

After this episode of Mayo Clinic’s cardiovascular podcast series “Interviews With the Experts,” the listener will be able to identify the novel 2024 ACC Expert Care Decision Pathway (ECDP) 4-stage classifications of myocarditis. Hear today’s expert discuss pivotal tests in the diagnosis of myocarditis, such as cardiac magnetic resonance (CMR) imaging and endomyocardial biopsy (EMB) are considered. Finally, learn more about the indications for genetic testing for myocarditis in your patients.

Topics Discussed:
• What percentage of adult patients with myocarditis presenting as heart failure with reduced ejection fraction or ventricular arrhythmias have a pathogenic or likely pathogenic cardiomyopathic gene variant?
• Which of the following are criteria to consider endomyocardial biopsy in the setting of acute myocarditis?
• Identify Stage B myocarditis based on clinical presentation and testing.

From Mayo Clinic to your inbox, sign-up for free: https://mayocl.in/3e71zfi

Visit Mayo Clinic: hhttps://www.mayoclinic.org/appointments?mc_id=us&utm_source=youtube&utm_medium=sm&utm_content=Uk86dSnHeTA&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100504

Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/
Follow Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/
Follow Mayo Clinic on X, formerly Twitter: https://x.com/MayoClinic
Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic
Category
Cardiology
Be the first to comment

Up Next